Talecris Biotherapeutics (TLCR) Reports Q4 Adj-EPS of 38c, Misses by 1c
Tweet Send to a Friend
Talecris Biotherapeutics Holdings Corp. (NASDAQ: TLCR) reported Q4 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
